INTRODUCTION

Stem Cell Innovations (SCI) has been in existence since early 2015 and has taken part in the progress and expansion of Stem Cell Research. SCI has conducted case studies domestically and internationally on Orthopedic (Feet, Hips, Spine, Knees, Shoulders, and Ankles.) Neurology (Multiple Sclerosis, Alzheimer, and Tumors.), Pulmonary (COPD), and Oncology (Leukemia). Before I digress further, let us understand the word stem cell. What is a stem cell?
Stem cells are a class of undifferentiated cells that are able to differentiate into specialized cell types. Normally, stem cells come from two core sources: Embryos formed during the blastocyst phase of embryological development which is called "embryonic stem cells" and secondly, the Adult tissue which is known as "adult stem cells". These two types of stem cells are generally categorized by their potency, or potential to differentiate into different cell types such as skin, muscle, bone, and so on. The founder and CEO of AVM Biotechnology, Dr. Theresa Deisher, once said that "Every person has stem cells in their own body . . . And while there are exceptions, when we want to treat someone with a disease, we can take their own stem cells and use their own stem cells to induce regeneration and recovery in that patient. That's the value of adult stem cells. They're safe. They work. And they're affordable."
Developments in stem cell treatments are creating new probabilities for patients with bone breaks and other ailments to get back to life more readily and without long-term problems. Because stem cells have the capacity to generate new cells or help repair damaged cells, they require only a boost.
According to stemcells21.com, stem cells are the supplier of healthy "replacement cells" which you are born with. They are assigned by your body to replace the damaged cells or those which are either old or in the process of dying. With the advent of time, when you start losing healthy cells, the system's recovery process becomes harder and longer. Eventually, your body loses its ability to heal properly due to age, life illness, and traumas.

Stem Cell Innovations emphases on research and development in the field of stem cell science, with the double aim of advancing human longevity and expanding access to stem cell treatments via front-line technology.

THE STEM CELL INNOVATIONS (SCI)

Stem Cell Innovations is persistent in its global research, expansion, and implementation of stem cell therapy. They labor to expand their network with professionals, laboratories, clinics, hospitals, and nonprofit organizations globally to further their research and development with a core goal to connect individuals who are in dire need of treatment with a dedicated team of professionals who can provide personalized solutions based on patient factors and demographics collected in the Stem cell Innovations dual blockchain-supported platform.
The processes of blockchain technology and smart contracts offer an opportunity in the healthcare system to reinvent decades-old systems of data sharing, storing, and management supporting stem cell data integrity and security while giving patients control over their own data. The Decentralization of the platform enables an SCI user to gain access to the SCI's network of stem cell services and therapies without waiting for time-consuming referrals, wait-lists for treatments, and access to their own information

WHY THE DUAL BLOCKCHAIN?

The first platform will be developed on an Ethereum base mainly for token utility, which will be power-driven by the ERC20 platform. The second blockchain will be a custom application designed and developed by SCI engineers made-to-order to fit the healthcare environment. The second blockchain is the Stem Cell Innovations blockchain (SCIChain) which will be for storing and processing patient stem cell records. To ensure the authorization of anyone to gain access to user data, the SCIChain will utilize a Hyperledger Fabric network. This Hyperledger Fabric network will be developed to use a smart contract. This protects user's data and securely save all users data on the blockchain via the SCIApplication

CRITERIA OF CREATING NEW NODES ON THE SCI BLOCKCHAIN

Developers must apply transparent encryption to protect sensitive data at the string or bit level in NoSQL databases (Cassandra, MongoDB, and HBase, etc.) and SQL databases (Microsoft SQL Server, Oracle, IBM DB2, MySQL, PostgreSQL, etc.);
Developers must define smart contracts using SCIChain to control who and what can access the data, including database administrators and other privileged users;
Developers must use SCI unique identification as a key and policy for management and operations, auditing capability on database transactions.

ADVANTAGES OF SCI USING HYPERLEDGER FABRIC NETWORK

1. SCI will have the capacity to define assets, like the data to be collected and stored;
2. SCI will have access to chain-code that improves security across the networks;
3. SCI will have the capacity to depend on the secure ledger system that verifies, audits, and resolves disputes;
4. SCI will guarantee privacy across various channels such as those within SCI's network;
5. SCI will offer transparency in transactions where information can be verified and confirmed by decoders;
6. SCI will develop consensus on how information is collected, stored, and distributed

SCIAPPLICATION

The application provides the platform users control over their own stem cell data while storing and processing that data in a decentralized way to ensure data integrity and security. The application can assist individuals to manage their personal health and wellness, promote healthy living, and allow access to the ecosystem of stem cell innovations. The application will enable healthcare professionals and other users to purchase and access the following:

• Cord blood services
• Medical supplies
• Acquiring synthetic stem cells at a discount rate, enabling the purchaser to save up to 70% of market price
• Conducting DNA ethnicity tests
• Contact stem cell consultant specialists round the clock.
• Enabling professionals (doctors) and discounted memberships for medical students to pay for online app annual membership fees.
• Child growth.
• Monitoring pregnancy (estimated delivery date (EDD), pregnancy calculation, parental iron replacement (The application will calculate the iron deficiency in pregnant women based on weight "kilograms/pound", age, height, and hemoglobin blood test)
• Body mass index calculation (BMI) – this is to check if someone is underweight, at a healthy weight, overweight or considered obese.
  and many more features.
  

  STEM CELL INNOVATIONS TOKEN INFORMATION

  Stem Cell Innovation token (SCI) is an Ethereum (ERC-20) base standard and it is a utility token that will be utilized across the Stem Cell Innovations ecosystem for purchases, and for users to access a full range of SCI products and services. Note that the figures below may be subject to change with ETH/USD exchange rates and volatility throughout the ICO.
  The PRE-SALE BONUS starts with 60% in the first week and reduces by 5% every other consecutive week till the end of the pre-sale.
  The MAIN-SALE BONUS starts with 30% in the first week and reduces by 5% every other consecutive week till the end of the pre-sale.

  • TOKEN NAME: SCIA
  • TOKEN TICKER: SCIA
  • TOKEN TYPE: ERC-20
  • TOTAL SUPPLY: 800,000,000 SCI
  • SOFT CAP: $3,000,000
  • HARDCAP: $36,000,000
  • PRICE PER TOKEN: $0.15
  • TOKEN AVAILABLE FOR SALE: 240,000,000 SCI
  • TOKEN SALE START DATE: SEPTEMBER 17, 2018.
  • TOKEN SALE END DATE: October 29, 2018
    TOKEN MAIN SALE START DATE: November 21, 2018
  • TOKEN MAIN SALE END DATE: JANUARY 17, 2019
  • ACCEPTED CRYPTOCURRENCIES AND FIAT: BITCOIN (BTC), EHEREUM (ETH), LITECOIN (LTC) FIAT (GOVERNMENT ISSUED CURRENCY)
  • MINIMUM PURCHASE PRE-SALE: $500
  • MINIMUM PURCHASE MAIN-SALE: 0.4 ETH
  • MAXIMUM PURCHASE: 4000 ETH
  • UNSOLD TOKEN: ALL WILL BE BURNED
  • RESTRICTED COUNTRIES: the UNITED STATES OF AMERICA, the PEOPLE'S REPUBLIC OF CHINA (EXCEPT
    HONG KONG, MACAU, AND TAIWAN), CUBA, IRAN, DEMOCRATIC PEOPLE'S
    REPUBLIC OF KOREA, SYRIA, CRIMEA REGION.

    PROCEDURES FOR PURCHASING SCI TOKEN CAN BE SEEN HERE

    TOKEN ALLOCATION

    

    • IT DEVELOPMENT AND R&D: 25%
    • MARKETING AND SALES: 20%
    • LEGAL: 5%
    • INTERNATIONAL EXPANSION AND PARTNERSHIP OF STEM CELL LABORATORIES: 15%
    • INFRASTRUCTURE AND PROJECT MANAGEMENT: 10%
    • LOBBYING STEM CELL US FDA: 6%
    • TEAM AND ADVISORS: 19%

    ROADMAP

    
    
    
    
    

    PARTNERS

    

    TEAM

    

    ADVISORY

    

    GET IN TOUCH WITH STEM CELL INNOVATIONS

    WEBSITE
    WHITEPAPER
    EMAIL
    TELEGRAM
    MEDIUM
    FACEBOOK
    TWITTER
    YOUTUBE

    ARTICLE WRITTEN BY MICKEY OBERABOR
    BOUNTYHIVE USERNAME # MICKIEZ